Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
ASP3291
print preview
bookmark
share with colleague
General Information
Company
Telsar Pharma Inc.
Description
Melanocortin (MC) receptor agonist
Molecular Target
Melanocortin (MC) receptor
Mechanism of Action
Melanocortin 1 receptor (MC1R) agonist
Latest Stage of Development
Phase I
Indication
Inflammatory bowel disease (IBD)
Partner
Drais Pharmaceuticals Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy